Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins.
The purpose of this article is to acknowledge the success of using intravenous immunoglobulins in children with Guillain-Barré syndrome and to review the literature. A 17-year-old African-American young lady with Guillain-Barré syndrome of 11-days duration underwent intravenous immunoglobulin treatment. Within 6 days, the patient was ambulating and was showing significant signs of improvement. The use of intravenous immunoglobulins in children with Guillain-Barré syndrome has been reported in only a few instances.
Shah
M
M
Department of Internal Medicine/Pediatrics, Tulane University School of Medicine, New Orleans, La., USA.
Weinberger
M
M
D000293:Adolescent; D003937:Diagnosis, Differential; D005158:Facial Paralysis / Q000175:diagnosis; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D011129:Polyradiculoneuropathy / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous